Answers are grounded in this paper and cite their sources.
The therapeutic efficacy of a new formulation that incorporates 0.2% IDU in glycyrrhizin gel has been tested on patients who suffer from herpes of the lips and nose. The preparation was significantly more effective than a commercial 0.5% IDU ointment. It reduced the healing time and produced an almost instantaneous relief from pain. The higher efficacy of the new preparation may be ascribed to the reported anti-inflammatory and antiviral activities of glycyrrhizin together with an enhanced permeation of the IDU through the skin.
No takes yet. Share an insight, caveat, or question.
Segal et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: